New project from IBG: An innovative drug delivery system will be developed for biliary tract cancer treatment
Izmir Biomedicine and Genome Centre (IBG) is undertaking a new project to develop a biotechnological drug carrier system for biliary tract cancer patients.
The project titled ‘Development of Biotechnological Drug Carrier System Targeted to Biomarkers Determined from Biliary Tract Cancer Patients’ is accepted within the scope of TÜBİTAK-2515 COST Support Programme.
Izmir Biomedicine and Genome Centre (IBG) researcher Prof. Dr Hülya Ayar Kayalı is the coordinator of the project, and the team of the project includes Prof. Dr İlkay Tuğba Ünek, Dokuz Eylül University Institute of Oncology, Department of Clinical Oncology, Prof. Dr Tarkan Ünek, Dokuz Eylül University Faculty of Medicine, Department of General Surgery, and Prof. Dr Mesut Akarsu, Dokuz Eylül University Faculty of Medicine, Department of Gastroenterology, Retired Faculty Member.
The project, to be carried out by Izmir Biomedicine and Genome Centre (IBG), aims to develop target-specific new-generation biotechnological drug carrier systems after determining biomarkers from biliary tract cancer patients. This innovative project is considered as a major step in cancer treatment and aims to improve the life quality of patients.